. Author manuscript; available in PMC: 2012 Mar 1.

Published in final edited form as: J Allergy Clin Immunol. 2011 Mar;127(3):654–660. doi: 10.1016/j.jaci.2010.12.1111

Table 1. Baseline characteristics of subjects randomized to active or placebo intervention.

	Active	Placebo
Number	19	9
Median age, months	84 (38-126)	69 (28-114)
Sex	9 male, 10 female	9 male
Race	18 white, 1 biracial	9 white
Subjects with asthma	13 (68%)	7 (78%)
Subjects with atopic dermatitis	14 (74%)	4 (44%)
Subjects with allergic rhinitis	15 (79%)	8 (89%)
Subjects with other food allergy	14 (74%)	8 (89%)
Median baseline peanut IgE, kU/L^*	106 (31-685)	57 (20-188)
Median baseline titrated SPT, mm	7 (5.5-15)	7 (5.5-13)

p=0·02

IgE = immunoglobulin E, SPT = skin prick test